{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T22:45:35Z","timestamp":1773355535065,"version":"3.50.1"},"reference-count":24,"publisher":"American Academy of Pediatrics (AAP)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,2,1]]},"abstract":"<jats:sec>\n                  <jats:title>BACKGROUND AND OBJECTIVE:<\/jats:title>\n                  <jats:p>Reduction of critical asthma management time can reduce intensive care utilization. The goal of this study was to determine whether a Critical Asthma Standardized Clinical Assessment and Management Plan (SCAMP) can decrease length of critical asthma management time.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>METHODS:<\/jats:title>\n                  <jats:p>This retrospective study compared critical asthma management times in children managed before and after implementation of a Critical Asthma SCAMP. The SCAMP used an asthma severity score management scheme to guide stepwise escalation and weaning of therapies. The SCAMP guided therapy until continuous albuterol nebulization (CAN) was weaned to intermittent albuterol every 2 hours (q2h). Because the SCAMP was part of a quality improvement initiative in which all patients received a standardized therapy, informed consent was waived. The study was conducted in Medicine ICU and Intermediate Care Units in a tertiary care freestanding children\u2019s hospital. Children \u22652 years of age who had CAN initiated in the emergency department and were admitted to the Division of Medicine Critical Care with status asthmaticus were included. The time to q2h dosing from initiation of CAN was compared between the baseline and SCAMP cohorts. Adverse events were compared. The Mann-Whitney test was used for analysis; P values &amp;lt;.05 were considered statistically significant.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>RESULTS:<\/jats:title>\n                  <jats:p>There were 150 baseline and 123 SCAMP patients eligible for analysis. There was a decrease in median time to q2h dosing after the SCAMP (baseline, 21.6 hours [interquartile range, 3.2\u201332.3 hours]; SCAMP, 14.2 hours [interquartile range, 9.0\u201323.1 hours]; P &amp;lt; .01). There were no differences in adverse events or readmissions.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>CONCLUSIONS:<\/jats:title>\n                  <jats:p>A Critical Asthma SCAMP was effective in decreasing time on continuous albuterol.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1542\/hpeds.2016-0087","type":"journal-article","created":{"date-parts":[[2017,2,1]],"date-time":"2017-02-01T09:35:37Z","timestamp":1485941737000},"page":"79-87","source":"Crossref","is-referenced-by-count":20,"title":["A Critical Asthma Standardized Clinical and Management Plan Reduces Duration of Critical Asthma Therapy"],"prefix":"10.1542","volume":"7","author":[{"given":"Jackson","family":"Wong","sequence":"first","affiliation":[{"name":"Divisions of Medicine Critical Care and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael S.D.","family":"Agus","sequence":"additional","affiliation":[{"name":"Divisions of Medicine Critical Care and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dionne A.","family":"Graham","sequence":"additional","affiliation":[{"name":"Institute for Relevant Clinical Data Analytics"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elliot","family":"Melendez","sequence":"additional","affiliation":[{"name":"Divisions of Medicine Critical Care and"},{"name":"Emergency Medicine, Boston Children\u2019s Hospital, Harvard Medical School, Boston, Massachusetts; and"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"417","published-online":{"date-parts":[[2017,2,1]]},"reference":[{"issue":"17","key":"2021120817224763100_B1","first-page":"547","article-title":"Vital signs: asthma prevalence, disease characteristics, and self-management education: United States, 2001-2009","volume":"60","author":"Centers for Disease Control and Prevention (CDC)","year":"2011","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"2","key":"2021120817224763100_B2","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1007\/s10198-005-0277-2","article-title":"Costs of hospitalization for severe acute asthma of patients not treated according to guidelines and recommendations. French prospective study of 169 cases","volume":"6","author":"Sailly","year":"2005","journal-title":"Eur J Health Econ"},{"issue":"4","key":"2021120817224763100_B3","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2009-3239","article-title":"Trends in admissions for pediatric status asthmaticus in New Jersey over a 15-year period","volume":"126","author":"Hartman","year":"2010","journal-title":"Pediatrics"},{"issue":"4","key":"2021120817224763100_B4","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1097\/PCC.0b013e318238b428","article-title":"Critical care for pediatric asthma: wide care variability and challenges for study","volume":"13","author":"Bratton","year":"2012","journal-title":"Pediatr Crit Care Med"},{"issue":"3","key":"2021120817224763100_B5","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.jpeds.2005.05.008","article-title":"Regional variation in ICU care for pediatric patients with asthma","volume":"147","author":"Bratton","year":"2005","journal-title":"J Pediatr"},{"issue":"3","key":"2021120817224763100_B6","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1097\/PCC.0b013e3181ce6d19","article-title":"Heliox for children with acute asthma: has the sun set on this therapy?","volume":"11","author":"Carroll","year":"2010","journal-title":"Pediatr Crit Care Med"},{"issue":"3","key":"2021120817224763100_B7","first-page":"356","article-title":"Helium\/oxygen-driven albuterol nebulization in the management of children with status asthmaticus: a randomized, placebo-controlled trial","volume":"11","author":"Bigham","year":"2010","journal-title":"Pediatr Crit Care Med"},{"issue":"4","key":"2021120817224763100_B8","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1542\/peds.2007-0409","article-title":"Childhood overweight increases hospital admission rates for asthma","volume":"120","author":"Carroll","year":"2007","journal-title":"Pediatrics"},{"issue":"3","key":"2021120817224763100_B9","first-page":"343","article-title":"Emergent endotracheal intubations in children: be careful if it\u2019s late when you intubate","volume":"11","author":"Carroll","year":"2010","journal-title":"Pediatr Crit Care Med"},{"issue":"3","key":"2021120817224763100_B10","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1002\/ppul.1110","article-title":"Impact of a pediatric asthma clinical pathway on hospital cost and length of stay","volume":"32","author":"Wazeka","year":"2001","journal-title":"Pediatr Pulmonol"},{"issue":"5","key":"2021120817224763100_B11","doi-asserted-by":"crossref","first-page":"480","DOI":"10.3109\/02770903.2014.887728","article-title":"Effectiveness of paediatric asthma clinical pathways: a narrative systematic review","volume":"51","author":"Chen","year":"2014","journal-title":"J Asthma"},{"issue":"4","key":"2021120817224763100_B12","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2013-0086","article-title":"Regional implementation of a pediatric cardiology chest pain guideline using SCAMPs methodology","volume":"132","author":"Angoff","year":"2013","journal-title":"Pediatrics"},{"issue":"5","key":"2021120817224763100_B13","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1377\/hlthaff.2012.0667","article-title":"Standardized Clinical Assessment and Management Plans (SCAMPs) provide a better alternative to clinical practice guidelines","volume":"32","author":"Farias","year":"2013","journal-title":"Health Aff (Millwood)"},{"key":"2021120817224763100_B14","doi-asserted-by":"crossref","first-page":"S94","DOI":"10.1016\/j.jaci.2007.09.029","article-title":"Expert Panel Report 3 (EPR-3): guidelines for the diagnosis and management of asthma\u2014summary report 2007","volume":"120","author":"National Asthma Education and Prevention Program","year":"2007","journal-title":"J Allergy Clin Immunol"},{"issue":"2","key":"2021120817224763100_B15","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S0022-3476(97)70346-9","article-title":"Inhaled helium-oxygen revisited: effect of inhaled helium-oxygen during the treatment of status asthmaticus in children","volume":"130","author":"Kudukis","year":"1997","journal-title":"J Pediatr"},{"issue":"5","key":"2021120817224763100_B16","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1542\/peds.2004-2136","article-title":"Helium\/oxygen-driven albuterol nebulization in the treatment of children with moderate to severe asthma exacerbations: a randomized, controlled trial","volume":"116","author":"Kim","year":"2005","journal-title":"Pediatrics"},{"issue":"1","key":"2021120817224763100_B17","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.ajem.2005.06.007","article-title":"Albuterol nebulized in heliox in the initial ED treatment of pediatric asthma: a blinded, randomized controlled trial","volume":"24","author":"Rivera","year":"2006","journal-title":"Am J Emerg Med"},{"issue":"5","key":"2021120817224763100_B18","doi-asserted-by":"crossref","first-page":"424","DOI":"10.2223\/JPED.2034","article-title":"Use of helium-oxygen mixture (Heliox\u00ae) in the treatment of obstructive lower airway disease in a pediatric emergency department","volume":"86","author":"Braun Filho","year":"2010","journal-title":"J Pediatr (Rio J)"},{"issue":"1","key":"2021120817224763100_B19","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.anai.2013.09.024","article-title":"Heliox-driven \u03b22-agonists nebulization for children and adults with acute asthma: a systematic review with meta-analysis","volume":"112","author":"Rodrigo","year":"2014","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"5","key":"2021120817224763100_B20","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1378\/chest.109.5.1256","article-title":"Evaluation of heliox in children hospitalized with acute severe asthma. A randomized crossover trial","volume":"109","author":"Carter","year":"1996","journal-title":"Chest"},{"issue":"2","key":"2021120817224763100_B21","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1097\/00003246-197303000-00001","article-title":"Intravenous isoproterenol infusion in children with severe hypercapnia due to status asthmaticus. Effects on ventilation, circulation, and clinical score","volume":"1","author":"Downes","year":"1973","journal-title":"Crit Care Med"},{"issue":"6","key":"2021120817224763100_B22","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1067\/mpd.2000.110121","article-title":"The Preschool Respiratory Assessment Measure (PRAM): a responsive index of acute asthma severity","volume":"137","author":"Chalut","year":"2000","journal-title":"J Pediatr"},{"issue":"3","key":"2021120817224763100_B23","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/S1081-1206(10)60987-8","article-title":"A modified pulmonary index score with predictive value for pediatric asthma exacerbations","volume":"94","author":"Carroll","year":"2005","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"4","key":"2021120817224763100_B24","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1111\/j.1747-0803.2010.00438.x","article-title":"A novel approach to gathering and acting on relevant clinical information: SCAMPs","volume":"5","author":"Rathod","year":"2010","journal-title":"Congenit Heart Dis"}],"container-title":["Hospital Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/publications.aap.org\/hospitalpediatrics\/article-pdf\/7\/2\/79\/814111\/hpeds_2016-0087.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/publications.aap.org\/hospitalpediatrics\/article-pdf\/7\/2\/79\/814111\/hpeds_2016-0087.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,8]],"date-time":"2021-12-08T17:54:10Z","timestamp":1638986050000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.aap.org\/hospitalpediatrics\/article\/7\/2\/79\/26453\/A-Critical-Asthma-Standardized-Clinical-and"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2,1]]},"references-count":24,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2017,2,1]]},"published-print":{"date-parts":[[2017,2,1]]}},"URL":"https:\/\/doi.org\/10.1542\/hpeds.2016-0087","relation":{},"ISSN":["2154-1663","2154-1671"],"issn-type":[{"value":"2154-1663","type":"print"},{"value":"2154-1671","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,2,1]]}}}